BZBin Zhang

Bin Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bin Zhang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Zheng

    Department of Cardiology, Peking University First Hospital, Beijing, China

    1 shared publication
  • Bo Zheng

    Yuhuan People’s Hospital, Taizhou, China

    1 shared publication
  • Chang Hou

    Department of Cardiology

    1 shared publication
  • Dunliang Ma

    Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China

    1 shared publication
  • Feihuang Han

    Department of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

    1 shared publication
  • Hao Li

    Knuppe Molecular Urology Laboratory, Department of Urology, School of Medicine, University of California, San Francisco, San Francisco, United States; Department of Urology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology, Wuhan, China, China

    1 shared publication

Latest Publications

  • Retrograde‐Guided Antegrade Puncture Reentry Technique for Retrograde CTO PCI: Procedural Outcome and Safety Evaluation

    by Zehan Huang, QiHeng Wan, YaoJun Zhang, FeiHuang Han, DunLiang Ma, Wang Feng, Yuqing Huang, LiTian Lin, Bin Zhang

    Background: Improving the efficiency of traversing the occluded segment is important in retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We developed the retrograde‐guided antegrade puncture reentry (RPR) technique to improve procedural efficiency while maintaining safety in retrograde CTO PCI. Methods: This retrospective study included 336 patients who underwent retrograde CTO PCI between July 2024 and August 2025. Patients were categorized into the RPR group, the Non‐RPR group, and the Directly Crossing group. The primary outcome was CTO crossing time, defined as the interval from retrograde guidewire crossing of the collateral channel to wire externalization or wiring crossing into distal true lumen. Subgroup analyses were performed within the RPR cohort, and multivariate logistic regression was used to identify predictors of RPR success. Results: Despite higher lesion complexity in the RPR group, CTO crossing time was significantly shorter with RPR than with Non‐RPR strategies (13 [6–24.75] min vs. 25 [15–43] min; p < 0.001). Primary RPR achieved successful reentry in 67% of cases and demonstrated the shortest crossing time among all strategies. Failed RPR did not prolong subsequent bailout R‐CART. Complications were infrequent, including a 2.3% perforation rate, and no in‐hospital mortality in the RPR group. Calcification and occlusion length were independent predictors of RPR failure, whereas prior CTO PCI was associated with higher likelihood of RPR success. Conclusions: RPR is a safe and efficient adjunct to retrograde CTO PCI and may serve as an effective initial reentry strategy in selected cases.

  • Open Access

    Active Versus Conventional Side Branch Protection Strategy for Coronary Bifurcation Lesions

    by Qiao Qin, Bo Zheng, Jiahui Liu, Bin Zhang, Ming Chen, Jianping Li, Yong Huo

    The side branch (SB) provisional stenting strategy is currently the recommended approach for most coronary bifurcation lesions. However, this strategy may result in SB deterioration, which is associated with an increased incidence of periprocedural myocardial infarction (PMI) and may adversely affect the long-term prognosis. Various techniques for SB protection (SB-P) have been developed to reduce SB occlusion and improve the clinical prognosis. This meta-analysis was performed to compare the outcomes of an active SB-P strategy of jailed balloon technique, balloon-stent kissing technique, and jailed Corsair technique versus the conventional SB-P strategy based on jailed wire technique.This meta-analysis included 5 studies (4 randomized and 1 observational) involving a total of 1,174 patients in whom the active and conventional SB-P strategies were compared. Fixed- and random-effects models were used to calculate summary risk ratios (RRs).The risk of SB occlusion was significantly lower in active SB-P strategy [RR 0.47, 95% confidence interval (CI) 0.30-0.73 in fixed-effect model; RR 0.52, 95% CI 0.31-0.87 in random-effect model]. The risk of PMI was similar between the two strategies (RR 0.63, 95% CI 0.30-1.33 in fixed-effect model; RR 0.71, 95%CI 0.20-2.48 in random-effect model). The rate of long-term major adverse cardiovascular events was similar between the groups (RR 0.48, 95% CI 0.15-1.48 in fixed-effect model; RR 0.49, 95% CI 0.16-1.52 in random-effect model).The active SB-P strategy in coronary bifurcation lesions is associated with reduced SB deterioration, but it does not decrease PMI or improve the long-term prognosis.


  • Open Access

    Culture and purification of SD rat corpus cavernosum endothelial cells by enzymatic digestion combined with mechanical extrusion and fixed‐point digestion

    by Ying Chen, Tao Qi, Shu‐Guang Zhu, Hao Li, Jia‐Xin Feng, Bin Zhang, Shi‐Xiong Li, Shuai Ma, Qiang Ma, Qing‐Jun Chu, et al.

    To explore a new method of in vitro culture and purification of rat corpus cavernosum endothelial cells (CCECs). Male Sprague-Dawley rats' penile tissue were digested with elastase or collagenase combined with mechanical extrusion to isolate and culture the CCECs. The fixed-point digestion method was used to purify the primary cells. High-purity CCECs were successfully isolated. Following the digestion of the primary CCECs by elastase or collagenase coupled with mechanical extrusion, the cells were paving stone- and cobblestone-shaped over 10 days. The cell purity yielded in the second generation (P2) CCECs after using the fixed-point digestion method was significantly high. Compared with primary CCECs extracted by elastase digestion combined with the mechanical extrusion method, CCECs cultured by collagenase digestion yielded higher purity and a more stable morphology after fixed-point digestion and purification. Immunofluorescence staining of the third generation CCECs and the expression results of endothelial cell-associated marker antibodies CD31 and VWF were positive, and flow cytometry showed the purity of CCECs was 96.9%. Enzymatic digestion combined with mechanical extrusion and fixed-point digestion is a simple, economical method for in vitro culture and purification of CCECs, which is conducive to studying the pathophysiological mechanisms of endothelial dysfunction and erectile dysfunction.


  • Open Access

    Second-generation non-invasive high-throughput DNA sequencing technology in the screening of Down's syndrome in advanced maternal age women

    by Jiao Zhang, BIN Zhang

    The aim of the present study was to evaluate the efficacy of using non-invasive DNA testing technology in screening Down's syndrome among women of advanced maternal age (AMA) and to provide evidence for prenatal screening of Down's syndrome. With a double-blind design, 8 ml of peripheral venous blood samples were collected from 87 women aged ≥35 years after 12 weeks of pregnancy. All cases were recorded with unique identification cards with clinical details and followed up until delivery. All the non‑invasive prenatal testing results were confirmed by amniotic fluid fetal karyotyping (the gold standard of aneuploidy test), follow‑up examination by neonatologists or neonatal blood karyotyping. The sensitivity, specificity and other indicators of non‑invasive DNA testing technology were calculated based on the data of 87 women of AMA. Among the 87 women of AMA, 5 were cases with abnormal numbers of chromosomes (3 cases of trisomy 21, 1 case of trisomy 18 and 1 case of 47, XXX). The sensitivity and specificity reached 100% for trisomy 21, trisomy 18 and 47, XXX. The present study supports that non‑invasive DNA testing is a useful method of AMA screening of Down's syndrome with 100% accuracy. Therefore, it can be used as an important alternative screening method for Down's syndrome in women of AMA.